Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib

被引：22

作者：

Grassinger, J

Südhoff, T

Andreesen, R

Hennemann, B ^{[1
]}

机构：

[1] Univ Regensburg, Dept Hematol & Oncol, D-93042 Regensburg, Germany

[2] Klinikum Passau, Dept Hematol & Oncol, D-94032 Passau, Germany

来源：

ANNALS OF HEMATOLOGY | 2006年 / 85卷 / 02期

关键词：

D O I：

10.1007/s00277-005-0027-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：132 / 133

页数：2

共 6 条

[1]

BERNASCONI C, 1989, EUR J HAEMATOL, V43, P76

[2]

Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x

[3] Bortezomib is an efficient agent in plasma cell leukemias [J].

Esparís-Ogando, A ;

Alegre, A ;

Aguado, B ;

Mateo, G ;

Gutiérrez, N ;

Bladé, J ;

Schenkein, D ;

Pandiella, A ;

San Miguel, JF .

INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (04) :665-667

[4] A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma [J].

Jagannath, S ;

Barlogie, B ;

Berenson, J ;

Siegel, D ;

Irwin, D ;

Richardson, PG ;

Niesvizky, R ;

Alexanian, R ;

Limentani, SA ;

Alsina, M ;

Adams, J ;

Kauffman, M ;

Esseltine, DL ;

Schenkein, DP ;

Anderson, KC .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (02) :165-172

[5] PLASMA-CELL LEUKEMIA - REPORT ON 17 CASES [J].

KYLE, RA ;

MALDONADO, JE ;

BAYRD, ED .

ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (05) :813-817

[6] A phase 2 study of bortezomib in relapsed, refractory myeloma [J].

Richardson, PG ;

Barlogie, B ;

Berenson, J ;

Singhal, S ;

Jagannath, S ;

Irwin, D ;

Rajkumar, SV ;

Srkalovic, G ;

Alsina, M ;

Alexanian, R ;

Siegel, D ;

Orlowski, RZ ;

Kuter, D ;

Limentani, SA ;

Lee, S ;

Hideshima, T ;

Esseltine, DL ;

Kauffman, M ;

Adams, J ;

Schenkein, DP ;

Anderson, KC .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2609-2617

← 1 →